Good day, everyone and welcome to the Torchmark Corporation Fourth Quarter 2016 Earnings Release Conference Call. Today's conference is being recorded. For opening remarks and introductions, I would like to turn the conference over to Mike Majors, VP of Investor Relations. Please go ahead Sir.

Thank you. Good morning, everyone. Joining the call today are, Gary Coleman and Larry Hutchison, our Co-Chief Executive Officers; Frank Svoboda, our Chief Financial Officer; and Brian Mitchell, our General Counsel. Some of our comments or answers to your questions may contain forward-looking statements that are provided for general guidance purposes only. Accordingly, please refer to our 2015 10-K and any subsequent forms 10-Q on file with the SEC. Some of our comments may also contain non-GAAP measures. Please see our earnings release and website for a discussion of these terms and reconciliations to GAAP measures. I will now turn the call over to Gary Coleman.

Thank you, Mike, and good morning everyone. In the fourth quarter, net income was $135 million or $1.12 per share, a 5% increase on a per share basis. Net operating income from continuing operations for the quarter was $139 million or $1.15 per share, a per share increase of 10% from a year ago. On a GAAP reported basis, return on equity as of December 31 was 12% and book value per share was $37.76 excluding unrealized gains and losses on fixed maturities. Return on equity was 14.6% and book value per share was $32.13, a 7% increase from a year ago. In our life insurance operations, premium revenue grew 6% to $550 million while life underwriting margin was $143 million, down 1% from a year. The decline in underwriting margin is due primarily to the decline in the direct response margins. In 2017, we expect life underwriting income to grow around 1% to 3%. Net life sales were $99 million, approximately the same as a year ago quarter. On the health side, premium revenue grew 1% to $238 million and health underwriting margin was up 4% to $53 million. In 2017, we expect health underwriting income to remain relatively flat. Health sales in total were $47 million down 21% from year ago. Individual health sales was $37 million down 4%. The administrative expenses were $50 million for the quarter up 6% from a year ago and in line with our expectations. As a percentage of premium from continuing operations, administrative expenses were 6.4% compared to 6.3% a year ago. For the full year, administrative expenses were $197 million or 6.3% of premium. In 2017, we expect administrative expenses to grow approximately 5% and to remain around 6.3% of premium. I'll now turn the call over to Larry Hutchison for his comments on the marketing operations.

Thank you, Gary. At American Income life premiums were up 11% to $236 million and life underwriting margin was up 10% to $75 million and life sales were $52 million up 3% due primarily to increased agent count. The average agent in the fourth quarter was 6,874 up 4% from a year ago and down 2% from the third quarter. The producing agent count at the end of the fourth quarter was 6,870. We expect the producing count to be in the range of 7,100 to 7,400 at the end of 2,017. Life sales for the full year 2016 grew 6%. We expect 6% to 10% life sales for 2017. At Liberty National life premiums were $67, approximately the same as the year ago quarter, while life underwriting margin was $19 million down 4%. Net life sales increased 15% to $10 million while net health sales were $5 million, approximately the same as the year ago quarter. The life sales increase was driven primarily by improvements in agent count. The average producing agent count for the fourth quarter was 1,781 up 16% from a year ago and down 1% compared to the third quarter. The producing agent count at Liberty National ended the quarter at 1,758. We expect the producing agent count to be in the range of 1800 to 2,000 and the end of 2017. Life net sales for the full year 2016 grew 12%. Life net sales growth is expected to be within the range of 8% to 12% for the full year 2017. Health net sales for the full year 2016 grew 8%. Health net sales growth in 2017 is expected to be between the range of 5% to 9%. We are enthusiastic about Liberty National's prospects. Life premiums grew on a year-over-year basis for both the…

I'll spend a few minutes discussing our investment operations. First, I'll talk about excess investment income. Excess investment income, which we define as net investment income as acquired interest on policy liabilities and debt was $58 million an 8% increase over the year ago quarter. On a per share basis, reflecting the impact of our share repurchase program, excess investment income was up 12%. In 2017, we expect excess investment income to grow by about 6% to 8%. However, on a per share basis, we should see an increase of about 9% to 11%. Now regarding Investment Portfolio, invested assets were $14.8 million, including $14.2 million of fixed maturities and amortized cost. At the amortized cost, $13.4 billion are investment grade with an average rating of A minus and below investment grade bonds are $751 million compared to $640 million a year ago. The percentage of below investment grade bonds to fixed maturities is 5.3% compared to 4.8% a year ago. The increase in global investment grade bonds is due primarily to downgrades in securities in the energy and mills and mining sectors that occurred earlier in 2016. However, due to the increase in the underlying commodity prices, the current market value of these securities are significantly higher than at the time of the downgrades. With a portfolio leverage of 3.7 times, the percentage of below grade bonds to equity excluding net unrealized gains on fixed maturities is 19%. Overall, the total portfolio is rated high BBB plus just slightly under the A minus a year ago. In addition, net unrealized gains in the fixed maturity portfolio of $1.1 billion, approximately $550 million higher than a year ago. Regarding investment yield, in the fourth quarter we invested $607 in investment grade fixed maturities, primarily in the industrial sectors. We invested…

Thanks Gary. First, I want to spend a few minutes discussing our share repurchases and capital position. In the fourth quarter we spend $71 million to buy $1.0 million Torchmark shares at an average price of $68.60. For the full year, we spent $311 million of parent company cash to acquire 5.2 million shares at an average price of $59.78. So far in 2017, we have spent $19 million to purchase 257,000 shares. The parent ended the year with liquid assets of about $45 million. In addition to these liquid asset, the parent will generate additional free cash flow in 2017. The parent company's free cash flow as we define it, results primarily from the dividends received by the parent from the subsidiaries less the interest paid on debt and the dividends paid to Torchmark's shareholders. While our 2016 statutory earnings have not yet been finalized, we expect free cash flow in 2017 to be in the range of $325 million to $335 million. Thus, including the assets on hand, at the beginning of the year, we currently expect to have around $370 million to $380 million of cash and liquid assets available to the parent during the year. This level of free cash flow in 2007 is slightly higher than 2016, primarily due to the net proceeds received in 2016 from the sale of our Medicare Part D business. As noted on previous calls, we will use our cash as efficiently as possible. If market conditions are favorable, we expect that share repurchases will continue to be a primary use of those funds. We also expect to retain approximately $50 million of parent assets at the end of 2017, absent the need to utilize any of these funds to support our insurance company operations. Now, regarding RBC at our…

Those are our comments. We’ll now open the call up for questions.

Thank you. [Operator Instructions] And we’ll go first to Jimmy Bhullar with JPMorgan.

All right. First I had a question on the annuity business, you’ve had pretty strong underwriting income in each of the last two quarters. What really drove that and I'm assuming it's lower amortization and stuff, but what really drove it and what's your expectation of a more normalized ongoing earnings number for that business?

Yeah. Hi, Jimmy. You're right that the increased income from the annuity business relates to lower amortization, but we slowed down the amortization of that business due to it staying on the books longer due to the lower interest rate environment, but going forward at the midpoint of our guidance, we see annuity income probably being in that $10 million range pretty similar to what we saw on a per quarter basis to what we have in the fourth quarter.

Okay. And then I think you mentioned retaining $50 million of liquidity at the holding company. In the past, I thought it was $50 million to $60 million. So not sure, has there been a change or is still consistent with what you were planning before?

Generally consistent, but I think looking realistically that we probably be at the lower end of that range, given our starting point where we ended up in 2016 a little below $50 million just really due to some timing of some items.

Okay. And then at the final numbers in terms of sales proceeds from the Part D block, do you have the final numbers on what you are expecting to get from the Part D sale?

The numbers are totally finalized until after the end of the first quarter.

Okay.

We did receive -- right now we estimate that the proceeds will be around $18 million, but probably to a little bit of adjustment still through the first quarter.

And then just lastly, how do you think about the impact of the exit on your investment income? I'm assuming at some point down the road, it should help your investment income. How do you think about how it affected this year, next year and the year after?

Yes, as the exit of the business occurs, we will receive the various receivables that we have on the Part D business. We did see a pickup here in 2016 as we collected a significant portion of our CMS receivables here in 2016. As of the end of 2016, we still have around $100 million of net receivable from that business. We expect to probably get around $80 million of that in 2017 and that will be fairly pro-rata over the course of the year. And then it looks like there'll be a little bit of detail on the final $20 million or so that we don't anticipate to receive from CMS until probably the end of 2018, just there is some review process as it takes a couple of years to exit the business.

So more normal number yield it will take till '19 to get to a more normal number on investment income and no lag effect from this?

Ultimately yes, so there is a little bit of a drag that we're going to see here in 2017. Probably around the $2 million to $3 million range of a net drag, but then ultimately it will be cleaned up for the most part by the end of the year into '19.

But Jimmy that's a comparison, excuse me, the drag in 2016 was $9 million. So, we hope for $9 to $2 million to $3 million.

Thank you.

And we’ll take our next question from Bob Glasspiegel with Janney.

Good morning Torchmark, direct response margins were flat sequentially, but you're guiding to further decline from the Q4 run rate in the 2017, have we turned the corner there or is it still a little bit of marginal deterioration?

Yeah Bob, I think we do anticipate having a little bit of marginal deterioration in 2017. And just to add, the 2002 through 2014 years related to RX business that we primarily do on the RX business that we talked about in the past as that really go through it's maturity if you will in its higher years and then and then starts to decline as an overall percentage of our premium. Looking past 2017 we really see it stabilizing for the most part in maybe that 14% to 15% range. So, there might be just a slight deterioration past 2017, but at this point in time, it’s really difficult to determine exactly until we see what impact the changes that we made at the end of '16 and on our 2017 sales will ultimately have.

Okay. Thank you. And one quick follow-up on the guidance on news rates for 2017 up 4.8. How does that compare to what you're getting today? Do we need a further increase in rates to get there?

No. Excuse me Bob, am battling a cold here. As we mentioned we invested 458 in the fourth quarter. So, for in this quarter, we are a little bit above what we thought where it would be -- we are in the high 480 range. What we contemplated is that the first quarter be around 470 and then would ratchet up to toward the end of the year it would be more -- just little under 5%. We now our goal to have to get to 480. We are little ahead of the game in the first part of the first quarter and of course we hope that continues.

Okay. You said you're getting above 480 now, I missed….

Yeah. Little above 480 right now.

Okay. Appreciated. Thank you.

[Operator Instructions] We’ll go next to John Nadel with Credit Suisse.

Hi, thanks for taking the question. If I look at amortized cost of your invested assets, I am thinking about the excess investment income calculation, you ended '16 with about $14.2 billion. I know there is a bunch of different cash flows, how much do you think that should -- should we be thinking about that growing in that 2% to 3% range annually or does there -- do we get a bump up with some of these proceeds?

Okay. John, you're talking about the growth in the fixed maturities assets?

The $14.2 billion of invested assets in your excess investment income count?

Yes. I think you can -- we’re looking at growth of 4% to 5% in the next two to three years.

Okay. Each year.

Yeah, each year, right.

Okay, that’s helpful. And then I have a -- I guess this is more of a hypothetical question. I understand your guidance doesn't contemplate any changes in statutory tax rates, that seems sensible even if something happens, it doesn't feel like it’s going to happen that soon. But hypothetically if domestic tax rates, corporate tax rates fell from 35% I don’t know, pick a number 20% or 25% or even lower, do you expect to be able to capture all that to the bottom line or would you expect to price new product sales differently perhaps generate a faster pace of sales growth and still target of similar after-tax ROE just recognizing that your profit margin, a greater proportion of your profit margin might come from a lower tax rate, you understand that -- I don’t know if I am phrasing that very well?

I think John I understand, I believe what your question is, it’s really hard to say with respect to the impact of the sales might happen and we obviously really haven’t spent any time really thinking about how we might adjust the pricing at all with respect to changing the tax rates. We would clearly see and would just say if tax rates were to decrease to 25%, we would expect there to be a decrease in the cash taxes we pay, but at this point in time we really don't know what change they might make on -- to the tax base to ease into that to some degree.

Understood.

We would and we should end up having a benefit on the GAAP side clearly. On the statutory side, it's a little bit more difficult to see exactly how that might materialize and how that might impact future cash flows if you will.

Okay. I'm just curious -- it's more of a I guess a bit of a philosophical question right because I suppose at the end of the day, lower corporate tax rate is intended to help the consumer and grow the economy faster and so in that respect I guess I am wondered if you would target a higher ROE recognizing a lower tax rate or if you would just look to pass along savings in the form of a lower premium rate to customers.

Well, John, in our businesses the direct response we will consider more than others because there is more price competitive there. In our agency operations, it's not that price competitive. So, I think we would be careful about what we did with those premiums.

Okay. Understood. All right. I'll take it offline with you. Thank you.

And gentlemen, we have no further questions at this time. I'll turn it back to you for any additional or closing remarks.

All right. Thank you for joining us this morning. Those were our comments and we'll talk to you again next quarter.

Thank you. And that does conclude today's conference. Thank you for your participation. You may now disconnect.